City

Chicago (1)

Harbin (1)

Oak Park (1)

Condition

Doxorubicin Adverse Reaction (2)

Arrhythmia (1)

Breast Cancer (1)

Cancer (1)

Cardiomyopathies, Secondary (1)

Doxorubicin Induced Cardiomyopathy (1)

Heart Failure (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Monyan Pharmaceutical (Shanghai) Co., Ltd. (1)

Rush University Medical Center (1)

Collaborator

Intervention

control group:dh001 placebo (1)

trial group: dh001 high-dose group (1)

trial group: dh001 low-dose group (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

Doxorubicin Adverse Reaction

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001

Recruiting

Cancer
+4 more

Control group:DH001 placebo
+2 more

Harbin, Heilongjiang, China

Harbin Institute of Hematology and Cancer

Oct 20, 2023

Blood Samples of Breast Cancer Patients During and Post

Completed

Doxorubicin Adverse Reaction
+2 more

Chicago, Illinois
+1 more

Apr 23, 2021